In a study utilizing bladder cancer cell lines, CD46 overexpression enhanced the upregulation of MMP9 to trigger phosphorylation of p38 MAPK and PKB and to promote increased activity of activator protein 1 (AP-1) activity via c-Jun (69). Here, MMP9 is linked to urinary bladder carcinoma.